Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated acquired demyelinating neuropathy that is characterized by proximal and distal limb weakness, areflexia and sensory involvement [1]. In typical CIDP, clinical symptoms progress for more than eight weeks and follow a course of disease progression that is either progressive or relapsing-remitting. However, there are atypical presentations of CIDP including acute-onset CIDP [2], distal predominant subtype [distal acquired demyelinating symmetric neuropathy (DADS)], multifocal subtype [multifocal acquired demyelinating sensory and motor neuropathy (MADSAM)], focal, pure motor and pure sensory phenotypes.
Source: Neuromuscular Disorders - Category: Neurology Authors: Tags: Research paper Source Type: research